Cover Image
市場調查報告書

ADME毒性實驗的全球市場

Global ADME-Toxicology Testing Market 2015-2019

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 333140
出版日期 內容資訊 英文 97 Pages
訂單完成後即時交付
價格
Back to Top
ADME毒性實驗的全球市場 Global ADME-Toxicology Testing Market 2015-2019
出版日期: 2015年06月17日 內容資訊: 英文 97 Pages
簡介

ADME毒性實驗,是為了評估藥物分子的代謝與生物的毒性。ADME顯示生物內的藥物之藥理學性變化,在受管理的實驗室環境中in vivo或in vitro常規進行。全球ADME毒性測試市場,預計2014∼2019年以複合成長率10.65%擴大。

本報告提供全球ADME毒性測試市場之相關詳細分析、市場趨勢與2015∼2019年的成長預測、檢驗概要、in vivo、in vitro技術、各地區趨勢,及主要供應商簡介等彙整資料。

第1章 摘要整理

第2章 簡稱清單

第3章 本報告的範圍

第4章 市場調查方法

第5章 簡介

第6章 市場環境

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第7章 ADME毒性檢驗

第8章 各技術市場區隔

第9章 全球in vivo技術市場

第10章 全球in vitro技術市場

第11章 各地區市場區隔

  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區

第12章 購買標準

第13章 市場成長的促進要素

第14章 促進要素與其影響

第15章 市場課題

第16章 促進要素與課題的影響

第17章 市場趨勢

第18章 趨勢與其影響

第19章 供應商環境

  • 競爭模式
  • 市場佔有率調查:2014年
  • 其他傑出的供應商

第20章 主要供應商調查

  • Dassault Systemes
  • Agilent Technologies
  • Bio-Rad Laboratories Inc.
  • Promega
  • Sigma-Aldrich
  • Thermo Fisher Scientific

第21章 本系列的其他報告

圖表

目錄
Product Code: IRTNTR6195

About ADME-Toxicology Testing

ADME-toxicology testing is the evaluation of the metabolism of a drug molecule and its toxicity in an organism. ADME describes the pharmacological changes of a drug inside a living organism. These studies are traditionally carried out in vivo or in vitro in a controlled laboratory environment.

Technavio's analysts forecast the global ADME-toxicology testing market to grow at a CAGR of 10.65% over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the global ADME-toxicology testing market for the period 2015-2019. To calculate the market size, Technavio analysts consider revenue generated from the sales of products (instruments, assays systems, software solutions, and reagents) used in the following ADME-toxicology testing technologies:

  • In vivo: test performed inside a living organism for drug evaluation
  • In vitro: test performed in a laboratory (outside of a living cell)

This report provides the details about the market in the following there regions: Americas, APAC and EMEA.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Accelrys (Dassault Systemes)
  • Agilent Technologies
  • Bio-Rad Laboratories
  • Promega
  • Sigma Aldrich
  • Thermo Fisher Scientific

Other Prominent Vendors

  • Cyprtorex
  • CytoPulse
  • Entelos
  • LI-COR Biosciences
  • Mattek
  • Miltenyi Biotec
  • Molecular Toxicology
  • Quintiles
  • RTI Health Solutions
  • SBW
  • Xenobiotic Detection Systems
  • Xenometrix

Market Driver

  • Demand from Biotechnology and Pharmaceutical Companies
  • For a full, detailed list, view our report

Market Challenge

  • High Cost
  • For a full, detailed list, view our report

Market Trend

  • Advances in Technology
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. ADME-Toxicology Testing

08. Market Segmentation by Technology

09. Global In vivo Technology Market

  • 09.1. Market Overview
    • 09.1.1. Market Size and Forecast

10. Global In vitro Technology Market

  • 10.1. Market Overview
    • 10.1.1. Market Size and Forecast

11. Geographical Segmentation

  • 11.1. ADME-Toxicology Testing Market in Americas
    • 11.1.1. Market size and forecast
  • 11.2. ADME-Toxicology Testing Market in EMEA
    • 11.2.1. Market size and forecast
  • 11.3. ADME-Toxicology Testing Market in APAC
    • 11.3.1. Market size and forecast

12. Buying Criteria

13. Market Growth Drivers

14. Drivers and their Impact

15. Market Challenges

16. Impact of Drivers and Challenges

17. Market Trends

18. Trends and their Impact

19. Vendor Landscape

  • 19.1. Competitive Scenario
    • 19.1.1. Key News
    • 19.1.2. Mergers and Acquisitions
  • 19.2. Market Share Analysis 2014
    • 19.2.1. Accelrys (Acquired by Dassault Systemes)
    • 19.2.2. Agilent Technologies
    • 19.2.3. Bio-Rad Laboratories
    • 19.2.4. Promega
    • 19.2.5. Sigma-Aldrich
    • 19.2.6. Thermo Fisher Scientific
  • 19.3. Other Prominent Vendors

20. Key Vendor Analysis

  • 20.1. Dassault Systemes
    • 20.1.1. Key Facts
    • 20.1.2. Business Overview
    • 20.1.3. Product Segmentation
    • 20.1.4. Geographical Segmentation by Revenue 2013
    • 20.1.5. Business Strategy
    • 20.1.6. Recent Developments
    • 20.1.7. SWOT Analysis
  • 20.2. Agilent Technologies
    • 20.2.1. Key Facts
    • 20.2.2. Business Overview
    • 20.2.3. Business Segmentation by Revenue 2013
    • 20.2.4. Business Segmentation by Revenue 2012 and 2013
    • 20.2.5. Geographical Segmentation by Revenue 2013
    • 20.2.6. Business Strategy
    • 20.2.7. Recent Developments
    • 20.2.8. SWOT Analysis
  • 20.3. Bio-Rad Laboratories Inc.
    • 20.3.1. Key Facts
    • 20.3.2. Business Description
    • 20.3.3. Business Segmentation
    • 20.3.4. Business Strategy
    • 20.3.5. Revenue by Business Segmentation
    • 20.3.6. Revenue Comparison 2011 and 2012
    • 20.3.7. Revenue by Geographical Segmentation
    • 20.3.8. Key Information
    • 20.3.9. SWOT Analysis
  • 20.4. Promega
    • 20.4.1. Key Facts
    • 20.4.2. Business Overview
    • 20.4.3. Products and Services
    • 20.4.4. Recent Developments
    • 20.4.5. SWOT Analysis
  • 20.5. Sigma-Aldrich
    • 20.5.1. Key Facts
    • 20.5.2. Business Overview
    • 20.5.3. Business Segmentation
    • 20.5.4. Business Strategy
    • 20.5.5. Business Segmentation by Revenue
    • 20.5.6. Sales by Geography
    • 20.5.7. Key Developments
    • 20.5.8. SWOT Analysis
  • 20.6. Thermo Fisher Scientific
    • 20.6.1. Key Facts
    • 20.6.2. Business Overview
    • 20.6.3. Business Segmentation by Revenue 2014
    • 20.6.4. Business Segmentation by Revenue 2013 and 2014
    • 20.6.5. Geographical Segmentation by Revenue 2014
    • 20.6.6. Business Strategy
    • 20.6.7. Recent Developments
    • 20.6.8. SWOT Analysis

21. Other Reports in this Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global ADME-Toxicology Testing Market 2014-2019 ($ millions)
  • Exhibit 3: Various Pharmacological Activities of a Drug Inside the Body
  • Exhibit 4: ADME/Tox Properties
  • Exhibit 5: Segmentation of Global ADME-Toxicology Testing Market by Technology
  • Exhibit 6: Segmentation of Global ADME-Toxicology Testing Market by Technology in 2014
  • Exhibit 7: Global In Vivo Technology Market 2014-2019 ($ millions)
  • Exhibit 8: Global In Vitro Technology Market 2014-2019 ($ millions)
  • Exhibit 9: Segmentation of Global ADME-Toxicology Testing Market by Technology 2014-2019 ($ million)
  • Exhibit 10: Segmentation of Global ADME-Toxicology Testing Market by Technology 2014-2019
  • Exhibit 11: Segmentation of Global ADME-Toxicology Testing Market by Geography 2014-2019
  • Exhibit 12: ADME-Toxicology Testing in Americas 2014-2019 ($ million)
  • Exhibit 13: ADME-Toxicology Testing in EMEA 2014-2019 ($ million)
  • Exhibit 14: ADME-Toxicology Testing in APAC 2014-2019 ($ million)
  • Exhibit 15: Segmentation of Global ADME-Toxicology Testing Market by Geography 2014-2019 in ($ millions)
  • Exhibit 16: Segmentation of Global ADME-Toxicology Testing Market by Geography 2014-2019
  • Exhibit 17: Dassault Systemes Key Take-aways
  • Exhibit 18: Agilent Technologies Key Take-aways
  • Exhibit 19: Bio-Rad Laboratories Key Take-aways
  • Exhibit 20: Promega Key Take-aways
  • Exhibit 21: Sigma-Aldrich Key Take-away
  • Exhibit 22: Thermo Fisher Scientific Key Take-aways
  • Exhibit 23: Dassault Systemes: Product Segmentation 2013
  • Exhibit 24: Dassault Systemes: Geographical Segmentation by Revenue 2013
  • Exhibit 25: Agilent Technologies: Business Segmentation by Revenue 2013
  • Exhibit 26: Agilent Technologies: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 27: Agilent Technologies: Geographical Segmentation by Revenue 2013
  • Exhibit 28: Bio-Rad Laboratories Inc.: Business Segmentation
  • Exhibit 29: Bio-Rad Laboratories Inc.: Revenue by Business Segmentation 2012
  • Exhibit 30: Bio-Rad Laboratories Inc.: Revenue Comparison by Business Segmentation 2011 and 2012 (US$ million)
  • Exhibit 31: Bio-Rad Laboratories Inc.: Revenue by Geographical Segmentation 2012
  • Exhibit 32: Promega: Key Products and Services
  • Exhibit 33: Sigma-Aldrich: Business Segmentation
  • Exhibit 34: Sigma-Aldrich: Business Segmentation by Revenue 2013
  • Exhibit 35: Sigma-Aldrich: Geographical Segmentation by Revenue 2013
  • Exhibit 36: Thermo Fisher Scientific: Business Segmentation by Revenue 2014
  • Exhibit 37: Thermo Fisher Scientific: Business Segmentation by Revenue 2013 and 2014 ($ billion)
  • Exhibit 38: Thermo Fisher Scientific: Geographical Segmentation by Revenue 2014
Back to Top